Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Children with SARS-CoV-2 in the National COVID Cohort Collaborative (N3C)

View ORCID ProfileBlake Martin, View ORCID ProfilePeter E. DeWitt, View ORCID ProfileSeth Russell, View ORCID ProfileAdit Anand, View ORCID ProfileKatie R. Bradwell, View ORCID ProfileCarolyn Bremer, View ORCID ProfileDavera Gabriel, View ORCID ProfileAndrew T. Girvin, View ORCID ProfileJanos G. Hajagos, View ORCID ProfileJulie A. McMurry, View ORCID ProfileAndrew J. Neumann, View ORCID ProfileEmily R. Pfaff, View ORCID ProfileAnita Walden, View ORCID ProfileJacob T. Wooldridge, View ORCID ProfileYun Jae Yoo, View ORCID ProfileJoel Saltz, View ORCID ProfileKen R. Gersing, View ORCID ProfileChristopher G. Chute, View ORCID ProfileMelissa A. Haendel, View ORCID ProfileRichard Moffitt, View ORCID ProfileTellen D. Bennett
doi: https://doi.org/10.1101/2021.07.19.21260767
Blake Martin
1Section of Critical Care Medicine, Department of Pediatrics, University of Colorado School of Medicine, University of Colorado, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Blake Martin
  • For correspondence: Blake.Martin@cuanschutz.edu
Peter E. DeWitt
2Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, University of Colorado, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter E. DeWitt
Seth Russell
2Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, University of Colorado, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Seth Russell
Adit Anand
3Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adit Anand
Katie R. Bradwell
4Palantir Technologies, Denver, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katie R. Bradwell
Carolyn Bremer
3Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carolyn Bremer
Davera Gabriel
5Johns Hopkins University School of Medicine, Baltimore, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Davera Gabriel
Andrew T. Girvin
4Palantir Technologies, Denver, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew T. Girvin
Janos G. Hajagos
3Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Janos G. Hajagos
Julie A. McMurry
6Translational and Integrative Sciences Center, University of Colorado, Aurora, CO, USA
7Center for Health AI, University of Colorado, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julie A. McMurry
Andrew J. Neumann
6Translational and Integrative Sciences Center, University of Colorado, Aurora, CO, USA
7Center for Health AI, University of Colorado, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew J. Neumann
Emily R. Pfaff
8North Carolina Translational and Clinical Sciences Institute (NC TraCS), University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emily R. Pfaff
Anita Walden
7Center for Health AI, University of Colorado, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anita Walden
Jacob T. Wooldridge
3Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jacob T. Wooldridge
Yun Jae Yoo
3Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yun Jae Yoo
Joel Saltz
3Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joel Saltz
Ken R. Gersing
9National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ken R. Gersing
Christopher G. Chute
5Johns Hopkins University School of Medicine, Baltimore, MD, USA
10Schools of Public Health, and Nursing, Johns Hopkins University, Baltimore, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher G. Chute
Melissa A. Haendel
7Center for Health AI, University of Colorado, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Melissa A. Haendel
Richard Moffitt
3Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard Moffitt
Tellen D. Bennett
1Section of Critical Care Medicine, Department of Pediatrics, University of Colorado School of Medicine, University of Colorado, Aurora, CO, USA
2Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, University of Colorado, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tellen D. Bennett
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance SARS-CoV-2

Objective To determine the characteristics, changes over time, outcomes, and severity risk factors of SARS-CoV-2 affected children within the National COVID Cohort Collaborative (N3C)

Design Prospective cohort study of patient encounters with end dates before May 27th, 2021.

Setting 45 N3C institutions

Participants Children <19-years-old at initial SARS-CoV-2 testing

Main Outcomes and Measures Case incidence and severity over time, demographic and comorbidity severity risk factors, vital sign and laboratory trajectories, clinical outcomes, and acute COVID-19 vs MIS-C contrasts for children infected with SARS-CoV-2.

Results 728,047 children in the N3C were tested for SARS-CoV-2; of these, 91,865 (12.6%) were positive. Among the 5,213 (6%) hospitalized children, 685 (13%) met criteria for severe disease: mechanical ventilation (7%), vasopressor/inotropic support (7%), ECMO (0.6%), or death/discharge to hospice (1.1%). Male gender, African American race, older age, and several pediatric complex chronic condition (PCCC) subcategories were associated with higher clinical severity (p≤0.05). Vital signs (all p≤0.002) and many laboratory tests from the first day of hospitalization were predictive of peak disease severity. Children with severe (vs moderate) disease were more likely to receive antimicrobials (71% vs 32%, p<0.001) and immunomodulatory medications (53% vs 16%, p<0.001).

Compared to those with acute COVID-19, children with MIS-C were more likely to be male, Black/African American, 1-to-12-years-old, and less likely to have asthma, diabetes, or a PCCC (p<0.04). MIS-C cases demonstrated a more inflammatory laboratory profile and more severe clinical phenotype with higher rates of invasive ventilation (12% vs 6%) and need for vasoactive-inotropic support (31% vs 6%) compared to acute COVID-19 cases, respectively (p<0.03).

Conclusions In the largest U.S. SARS-CoV-2-positive pediatric cohort to date, we observed differences in demographics, pre-existing comorbidities, and initial vital sign and laboratory test values between severity subgroups. Taken together, these results suggest that early identification of children likely to progress to severe disease could be achieved using readily available data elements from the day of admission. Further work is needed to translate this knowledge into improved outcomes.

Competing Interest Statement

Dr. Bennett reported receiving grants from the National Institutes of Health (NIH)/National Center for Advancing Translational Sciences (NCATS) during the conduct of the study and grants from the NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development and NIH/National Institute of Allergy and Infectious Diseases outside the submitted work. Dr. Moffitt reported receiving grants from the NIH during the conduct of the study. Dr. Hajagos reported receiving grants from the NIH/NCATS during the conduct of the study. Dr. Bradwell reported being employed by Palantir Technologies during the conduct of the study and outside the submitted work. Ms. Gabriel reported receiving grants from the NIH/NCATS during the conduct of the study. Dr. Girvin reported being an employee of Palantir Technologies. Ms. McMurry reported being a cofounder of Pryzm Health outside the submitted work. Dr. Pfaff reported receiving grants from the NIH/NCATS during the conduct of the study. Dr. Haendel reported receiving grants from the NIH during the conduct of the study. Dr. Chute reported receiving grants from the NIH/NCATS during the conduct of the study. No conflicts of interest reported for all other authors.

Funding Statement

Declaration of Interests / Conflict of Interest Disclosures: Dr. Bennett reported receiving grants from the National Institutes of Health (NIH)/National Center for Advancing Translational Sciences (NCATS) during the conduct of the study and grants from the NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development and NIH/National Institute of Allergy and Infectious Diseases outside the submitted work. Dr. Moffitt reported receiving grants from the NIH during the conduct of the study. Dr. Hajagos reported receiving grants from the NIH/NCATS during the conduct of the study. Dr. Bradwell reported being employed by Palantir Technologies during the conduct of the study and outside the submitted work. Ms. Gabriel reported receiving grants from the NIH/NCATS during the conduct of the study. Dr. Girvin reported being an employee of Palantir Technologies. Ms. McMurry reported being a cofounder of Pryzm Health outside the submitted work. Dr. Pfaff reported receiving grants from the NIH/NCATS during the conduct of the study. Dr. Haendel reported receiving grants from the NIH during the conduct of the study. Dr. Chute reported receiving grants from the NIH/NCATS during the conduct of the study. No conflicts of interest reported for all other authors. Funding / Support: The primary study sponsors are multiple institutes of the U.S. National Institutes of Health. The National Center for Advancing Translational Sciences is the primary steward of the N3C data and created the underlying architecture of the N3C Data Enclave, manages the Data Transfer Agreements and Data Use Agreements, houses the Data Access Committee, and supports contracts to vendors to help build various aspects of the N3C Data Enclave. Employees of the NIH and of the contracting companies are included as authors of the manuscript and participated in the writing and decision to submit the manuscript. The analyses for this work were conducted using data and tools accessed through the NCATS N3C Data Enclave and supported by NCATS U24 TR002306 (Drs Haendel, Chute, and Saltz; also supporting Dr. Pfaff, Ms. Walden, Ms. McMurry, Mr. Neumann and Ms. Gabriel). This study was also supported by numerous institutional grants associated with institutions with release data, see supplement for full list of grant numbers and institutions.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The N3C data transfer to NCATS is performed under a Johns Hopkins University Reliance Protocol # IRB00249128 or individual site agreements with NIH. Use of the N3C data for this study is authorized under the following IRB Protocols: - Site: University of Colorado; IRB Name: Colorado Multiple Institutional Review Board; Exempted vs approved: approved; Protocol Number:20-2225 - Site: Johns Hopkins University; IRB Name: Johns Hopkins Office of Human Subjects Research, Institutional Review Board ; Exempted vs approved: approved; Protocol number: IRB00249128 - Site: University of North Carolina; IRB name: University of North Carolina Chapel Hill Institutional Review Board; Exempted vs approved: exempted; Protocol number: 20-3106 - Site: Stony Brook University; IRB name: Office of Research Compliance, Division of Human Subject Protections, Stony Brook University; Exempted vs approved: exempted; Protocol number: IRB2020-00604

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • In the original version of figure 4 in the main manuscript, the obesity percentages reported were calculated using the total number of hospitalized children in each subgroup (MIS-C vs acute COVID-19) as the denominator (121/439 = 28% of MIS-C patients and 646/4251 = 15% of acute COVID-19 patients). The figure has been updated to reflect obesity percentages using as the denominator the number of children in each subgroup who were greater than or equal to 2 years-old and who had a BMI measurement available (121/373=32% for MIS-C and 646/2133=30% for acute COVID-19). This was our intended manner of displaying obesity percentages and is consistent with the CDC definition of obesity (that is, obesity is only defined in children greater than or equal to 2 years of age).

Data Availability

The N3C Data Enclave (covid.cd2h.org/enclave) houses fully reproducible, transparent, and broadly available limited and de-identified datasets (HIPAA definitions available at https://www.hhs.gov/hipaa/index.html). Enclave data can be accessed by investigators at institutions that have signed a Data Use Agreement with the NIH who have taken the required human subjects and security training and agree to the N3C User Code of Conduct. Those desiring access to the limited dataset need also supply an IRB protocol from their institution. Data access requests are reviewed by the NIH Data Access Committee. A full description of the N3C Enclave governance has been published (https://academic.oup.com/jamia/article/28/3/427/5893482) and additional information on the access application process is available on the NCATS website: https://ncats.nih.gov/n3c/about/applying-for-access. The data model utilized is OMOP 5.3.1, and specifications are available at: https://ncats.nih.gov/files/OMOP_CDM_COVID.pdf Additional N3C resources including code and governance documents are available within the project GitHub repositories and/or in Zenodo for archival purposes: https://github.com/National-COVID-Cohort-Collaborative https://zenodo.org/communities/cd2h-covid/

https://unite.nih.gov/

https://covid.cd2h.org/enclave

https://academic.oup.com/jamia/article/28/3/427/5893482

https://ncats.nih.gov/n3c/about/applying-for-access

https://ncats.nih.gov/files/OMOP_CDM_COVID.pdf

https://github.com/National-COVID-Cohort-Collaborative

https://zenodo.org/communities/cd2h-covid/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted July 23, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Children with SARS-CoV-2 in the National COVID Cohort Collaborative (N3C)
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Children with SARS-CoV-2 in the National COVID Cohort Collaborative (N3C)
Blake Martin, Peter E. DeWitt, Seth Russell, Adit Anand, Katie R. Bradwell, Carolyn Bremer, Davera Gabriel, Andrew T. Girvin, Janos G. Hajagos, Julie A. McMurry, Andrew J. Neumann, Emily R. Pfaff, Anita Walden, Jacob T. Wooldridge, Yun Jae Yoo, Joel Saltz, Ken R. Gersing, Christopher G. Chute, Melissa A. Haendel, Richard Moffitt, Tellen D. Bennett
medRxiv 2021.07.19.21260767; doi: https://doi.org/10.1101/2021.07.19.21260767
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Children with SARS-CoV-2 in the National COVID Cohort Collaborative (N3C)
Blake Martin, Peter E. DeWitt, Seth Russell, Adit Anand, Katie R. Bradwell, Carolyn Bremer, Davera Gabriel, Andrew T. Girvin, Janos G. Hajagos, Julie A. McMurry, Andrew J. Neumann, Emily R. Pfaff, Anita Walden, Jacob T. Wooldridge, Yun Jae Yoo, Joel Saltz, Ken R. Gersing, Christopher G. Chute, Melissa A. Haendel, Richard Moffitt, Tellen D. Bennett
medRxiv 2021.07.19.21260767; doi: https://doi.org/10.1101/2021.07.19.21260767

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pediatrics
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1437)
  • Dentistry and Oral Medicine (221)
  • Dermatology (158)
  • Emergency Medicine (293)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (590)
  • Epidemiology (10339)
  • Forensic Medicine (6)
  • Gastroenterology (534)
  • Genetic and Genomic Medicine (2658)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1746)
  • Health Policy (791)
  • Health Systems and Quality Improvement (683)
  • Hematology (270)
  • HIV/AIDS (571)
  • Infectious Diseases (except HIV/AIDS) (12123)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2486)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (498)
  • Occupational and Environmental Health (569)
  • Oncology (1338)
  • Ophthalmology (404)
  • Orthopedics (153)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (787)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2424)
  • Public and Global Health (5035)
  • Radiology and Imaging (903)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (258)
  • Sports Medicine (246)
  • Surgery (301)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)